Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways

► Malignant ascites is a significant cause of cancer-related death. ► Minocycline inhibits tumor growth and malignant ascites formation. ► Minocycline suppresses ascites and tumoral levels of VEGF, IL-6/sIL-6R and TGF-β1.